Resultats de la cerca - Jan‐Henning Klusmann

Refinar resultats
  1. 1
    Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood

    Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood per Susann Blüher, Peter Schwarz, Jan‐Henning Klusmann

    Publicat 2018
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Molecular Mechanisms of the Genetic Predisposition to Acute Megakaryoblastic Leukemia in Infants With Down Syndrome

    Molecular Mechanisms of the Genetic Predisposition to Acute Megakaryoblastic Leukemia in Infants With Down Syndrome per Juliane Grimm, Dirk Heckl, Jan‐Henning Klusmann

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Lost in translation: pluripotent stem cell‐derived hematopoiesis

    Lost in translation: pluripotent stem cell‐derived hematopoiesis per Mania Ackermann, Steffi Liebhaber, Jan‐Henning Klusmann, Nico Lachmann

    Publicat 2015
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia

    LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia per Stephan Emmrich, Alexandra Streltsov, Franziska Schmidt, Veera Raghavan Thangapandi, Dirk Reinhardt, Jan‐Henning Klusmann

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    RNA-Binding Proteins in Acute Leukemias

    RNA-Binding Proteins in Acute Leukemias per K Schuschel, Matthias Helwig, Stefan Hüttelmaier, Dirk Heckl, Jan‐Henning Klusmann, Jessica I. Hoell

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    Preclinical testing of miRNA-193b-3p mimic in acute myeloid leukemias

    Preclinical testing of miRNA-193b-3p mimic in acute myeloid leukemias per H Issa, R Bhayadia, Robert Winkler, Laura E. Swart, Dirk Heckl, Jan‐Henning Klusmann

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  7. 7
    The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study

    The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study per Jan‐Henning Klusmann, Dirk Reinhardt, Martin Zimmermann, Bernhard Kremens, Josef Vormoor, Michael Dworzak, Ursula Creutzig, T. Klingebiel

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells <i>in vivo</i>

    CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells <i>in vivo</i> per Jana Reimer, Sabine Knöß, Maurice Labuhn, Emmanuelle Charpentier, Gudrun Göhring, Brigitte Schlegelberger, Jan‐Henning Klusmann, Dirk Heckl

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells

    Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells per Basant Kumar Thakur, Tino Dittrich, Chandra Prakash, Annette Becker, Wolfgang Kuehnau, Jan‐Henning Klusmann, Dirk Reinhardt, Karl Welte

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial

    Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial per Jana Schweitzer, Martin Zimmermann, Mareike Rasche, Christine von Neuhoff, Ursula Creutzig, Michael Dworzak, Dirk Reinhardt, Jan‐Henning Klusmann

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Treatment and prognostic impact of transient leukemia in neonates with Down syndrome

    Treatment and prognostic impact of transient leukemia in neonates with Down syndrome per Jan‐Henning Klusmann, Ursula Creutzig, Martin Zimmermann, Michael Dworzak, Norbert Jorch, Claudia Langebrake, Arnulf Pekrun, Katarina Macakova-Reinhardt, Dirk Reinhardt

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis

    Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis per Jan‐Henning Klusmann, Frank J. Godinho, Kirsten Heitmann, Aliaksandra Maroz, Mia Lee Koch, Dirk Reinhardt, Stuart H. Orkin, Zhe Li

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    MicroRNA-125b-5p mimic inhibits acute liver failure

    MicroRNA-125b-5p mimic inhibits acute liver failure per Dakai Yang, Qinggong Yuan, Asha Balakrishnan, Heike Bantel, Jan‐Henning Klusmann, Michael P. Manns, Michael Ott, Tobias Cantz, Amar Deep Sharma

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia

    miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia per Jan‐Henning Klusmann, Zhe Li, Katarina Böhmer, Aliaksandra Maroz, Mia Lee Koch, Stephan Emmrich, Frank J. Godinho, Stuart H. Orkin, Dirk Reinhardt

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012

    Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012 per Mareike Rasche, Martin Zimmermann, Lisa Borschel, Jean‐Pierre Bourquin, Michael Dworzak, Thomas Klingebiel, Thomas Lehrnbecher, Ursula Creutzig, Jan‐Henning Klusmann, Dirk Reinhardt

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    <i>miR-99a/100∼125b</i> tricistrons regulate hematopoietic stem and progenitor cell homeostasis by shifting the balance between TGFβ and Wnt signaling

    <i>miR-99a/100∼125b</i> tricistrons regulate hematopoietic stem and progenitor cell homeostasis by shifting the balance between TGFβ and Wnt signaling per Stephan Emmrich, Mareike Rasche, Jennifer Schöning, Christina Reimer, Sarva Keihani, Aliaksandra Maroz, Ying Xie, Zhe Li, Axel Schambach, Dirk Reinhardt, Jan‐Henning Klusmann

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications

    Refined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications per Maurice Labuhn, Felix F. Adams, Michelle Ng, Sabine Knoess, Axel Schambach, Emmanuelle Charpentier, Adrian Schwarzer, Juan L. Mateo, Jan‐Henning Klusmann, Dirk Heckl

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial

    Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial per Madita Uffmann, Mareike Rasche, Martin Zimmermann, Christine von Neuhoff, Ursula Creutzig, Michael Dworzak, Lenie Scheffers, Henrik Hasle, C. Michel Zwaan, Dirk Reinhardt, Jan‐Henning Klusmann

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia

    Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia per Kate Alford, Katarina Reinhardt, Catherine Garnett, Alice Norton, Katarina Böhmer, Christine von Neuhoff, Alexandra Kolenová, Emanuele Marchi, Jan‐Henning Klusmann, Irene Roberts, Henrik Hasle, Dirk Reinhardt, Paresh Vyas

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study

    Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study per Marius Flasinski, Kira Scheibke, Martin Zimmermann, Ursula Creutzig, Katarina Reinhardt, Femke Verwer, Valérie de Haas, Vincent H. J. van der Velden, Christine von Neuhoff, C. Michel Zwaan, Dirk Reinhardt, Jan‐Henning Klusmann

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: